acetylsalicylic acid lysinate has been researched along with ST Elevated Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardo, E; Fernández-Ortiz, A; Gómez-Polo, JC; Jiménez, JJ; Martín-Asenjo, R; Moreno, G; Ortega-Pozzi, MA; Pérez-Villacastín, J; Vilacosta, I; Vivas, D | 1 |
| Crimi, G; Ferlini, M; Ferrario, M; Klersy, C; Leonardi, S; Mandurino Mirizzi, A; Marinoni, B; Montalto, C; Oltrona Visconti, L; Repetto, A; Somaschini, A | 1 |
1 trial(s) available for acetylsalicylic acid lysinate and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial.
Topics: Aspirin; Blood Platelets; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome | 2023 |
1 other study(ies) available for acetylsalicylic acid lysinate and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Aspirin; Coronary Care Units; Drug Monitoring; Female; Humans; Injections, Intravenous; Lysine; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Preoperative Care; Prospective Studies; ST Elevation Myocardial Infarction | 2021 |